Format
Sort by
Items per page

Send to

Choose Destination

Best matches for zhavoronkov+a or aliper+a:

A role for G-CSF and GM-CSF in nonmyeloid cancers. Aliper AM et al. Cancer Med. (2014)

Interactome analysis of myeloid-derived suppressor cells in murine models of colon and breast cancer. Aliper AM et al. Oncotarget. (2014)

Screening and personalizing nootropic drugs and cognitive modulator regimens in silico. Jellen LC et al. Front Syst Neurosci. (2015)

Search results

Items: 1 to 20 of 170

1.

Entangled Conditional Adversarial Autoencoder for de Novo Drug Discovery.

Polykovskiy D, Zhebrak A, Vetrov D, Ivanenkov Y, Aladinskiy V, Mamoshina P, Bozdaganyan M, Aliper A, Zhavoronkov A, Kadurin A.

Mol Pharm. 2018 Sep 19. doi: 10.1021/acs.molpharmaceut.8b00839. [Epub ahead of print]

PMID:
30180591
2.

Machine Learning on Human Muscle Transcriptomic Data for Biomarker Discovery and Tissue-Specific Drug Target Identification.

Mamoshina P, Volosnikova M, Ozerov IV, Putin E, Skibina E, Cortese F, Zhavoronkov A.

Front Genet. 2018 Jul 12;9:242. doi: 10.3389/fgene.2018.00242. eCollection 2018.

3.

Integrated transcriptomic and epigenomic analysis of ovarian cancer reveals epigenetically silenced GULP1.

Maldonado L, Brait M, Izumchenko E, Begum S, Chatterjee A, Sen T, Loyo M, Barbosa A, Poeta ML, Makarev E, Zhavoronkov A, Fazio VM, Angioli R, Rabitti C, Ongenaert M, Van Criekinge W, Noordhuis MG, de Graeff P, Wisman GBA, van der Zee AGJ, Hoque MO.

Cancer Lett. 2018 Oct 1;433:242-251. doi: 10.1016/j.canlet.2018.06.030. Epub 2018 Jun 28.

PMID:
29964205
4.

Reinforced Adversarial Neural Computer for de Novo Molecular Design.

Putin E, Asadulaev A, Ivanenkov Y, Aladinskiy V, Sanchez-Lengeling B, Aspuru-Guzik A, Zhavoronkov A.

J Chem Inf Model. 2018 Jun 25;58(6):1194-1204. doi: 10.1021/acs.jcim.7b00690. Epub 2018 Jun 12.

5.

Vive la radiorésistance!: converging research in radiobiology and biogerontology to enhance human radioresistance for deep space exploration and colonization.

Cortese F, Klokov D, Osipov A, Stefaniak J, Moskalev A, Schastnaya J, Cantor C, Aliper A, Mamoshina P, Ushakov I, Sapetsky A, Vanhaelen Q, Alchinova I, Karganov M, Kovalchuk O, Wilkins R, Shtemberg A, Moreels M, Baatout S, Izumchenko E, de Magalhães JP, Artemov AV, Costes SV, Beheshti A, Mao XW, Pecaut MJ, Kaminskiy D, Ozerov IV, Scheibye-Knudsen M, Zhavoronkov A.

Oncotarget. 2018 Feb 12;9(18):14692-14722. doi: 10.18632/oncotarget.24461. eCollection 2018 Mar 6. Review.

6.

Adversarial Threshold Neural Computer for Molecular de Novo Design.

Putin E, Asadulaev A, Vanhaelen Q, Ivanenkov Y, Aladinskaya AV, Aliper A, Zhavoronkov A.

Mol Pharm. 2018 Mar 30. doi: 10.1021/acs.molpharmaceut.7b01137. [Epub ahead of print]

PMID:
29569445
7.

Targeting focal adhesion kinase overcomes erlotinib resistance in smoke induced lung cancer by altering phosphorylation of epidermal growth factor receptor.

Solanki HS, Raja R, Zhavoronkov A, Ozerov IV, Artemov AV, Advani J, Radhakrishnan A, Babu N, Puttamallesh VN, Syed N, Nanjappa V, Subbannayya T, Sahasrabuddhe NA, Patil AH, Prasad TSK, Gaykalova D, Chang X, Sathyendran R, Mathur PP, Rangarajan A, Sidransky D, Pandey A, Izumchenko E, Gowda H, Chatterjee A.

Oncoscience. 2018 Feb 23;5(1-2):21-38. doi: 10.18632/oncoscience.395. eCollection 2018 Jan.

8.

Use of deep neural network ensembles to identify embryonic-fetal transition markers: repression of COX7A1 in embryonic and cancer cells.

West MD, Labat I, Sternberg H, Larocca D, Nasonkin I, Chapman KB, Singh R, Makarev E, Aliper A, Kazennov A, Alekseenko A, Shuvalov N, Cheskidova E, Alekseev A, Artemov A, Putin E, Mamoshina P, Pryanichnikov N, Larocca J, Copeland K, Izumchenko E, Korzinkin M, Zhavoronkov A.

Oncotarget. 2017 Dec 28;9(8):7796-7811. doi: 10.18632/oncotarget.23748. eCollection 2018 Jan 30.

9.

3D Molecular Representations Based on the Wave Transform for Convolutional Neural Networks.

Kuzminykh D, Polykovskiy D, Kadurin A, Zhebrak A, Baskov I, Nikolenko S, Shayakhmetov R, Zhavoronkov A.

Mol Pharm. 2018 Mar 5. doi: 10.1021/acs.molpharmaceut.7b01134. [Epub ahead of print]

PMID:
29473756
10.

Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy.

Ravi R, Noonan KA, Pham V, Bedi R, Zhavoronkov A, Ozerov IV, Makarev E, V Artemov A, Wysocki PT, Mehra R, Nimmagadda S, Marchionni L, Sidransky D, Borrello IM, Izumchenko E, Bedi A.

Nat Commun. 2018 Feb 21;9(1):741. doi: 10.1038/s41467-017-02696-6.

11.

Converging blockchain and next-generation artificial intelligence technologies to decentralize and accelerate biomedical research and healthcare.

Mamoshina P, Ojomoko L, Yanovich Y, Ostrovski A, Botezatu A, Prikhodko P, Izumchenko E, Aliper A, Romantsov K, Zhebrak A, Ogu IO, Zhavoronkov A.

Oncotarget. 2017 Nov 9;9(5):5665-5690. doi: 10.18632/oncotarget.22345. eCollection 2018 Jan 19.

12.

The Evaluation of Geroprotective Effects of Selected Flavonoids in Drosophila melanogaster and Caenorhabditis elegans.

Lashmanova E, Zemskaya N, Proshkina E, Kudryavtseva A, Volosnikova M, Marusich E, Leonov S, Zhavoronkov A, Moskalev A.

Front Pharmacol. 2017 Dec 7;8:884. doi: 10.3389/fphar.2017.00884. eCollection 2017.

13.

Population specific biomarkers of human aging: a big data study using South Korean, Canadian and Eastern European patient populations.

Mamoshina P, Kochetov K, Putin E, Cortese F, Aliper A, Lee WS, Ahn SM, Uhn L, Skjodt N, Kovalchuk O, Scheibye-Knudsen M, Zhavoronkov A.

J Gerontol A Biol Sci Med Sci. 2018 Jan 11. doi: 10.1093/gerona/gly005. [Epub ahead of print]

PMID:
29340580
14.

A method of gene expression data transfer from cell lines to cancer patients for machine-learning prediction of drug efficiency.

Borisov N, Tkachev V, Suntsova M, Kovalchuk O, Zhavoronkov A, Muchnik I, Buzdin A.

Cell Cycle. 2018;17(4):486-491. doi: 10.1080/15384101.2017.1417706. Epub 2018 Jan 17.

PMID:
29251172
15.

Residual γH2AX foci induced by low dose x-ray radiation in bone marrow mesenchymal stem cells do not cause accelerated senescence in the progeny of irradiated cells.

Pustovalova M, Astrelina ТA, Grekhova A, Vorobyeva N, Tsvetkova A, Blokhina T, Nikitina V, Suchkova Y, Usupzhanova D, Brunchukov V, Kobzeva I, Karaseva Т, Ozerov IV, Samoylov A, Bushmanov A, Leonov S, Izumchenko E, Zhavoronkov A, Klokov D, Osipov AN.

Aging (Albany NY). 2017 Nov 21;9(11):2397-2410. doi: 10.18632/aging.101327.

16.

Towards natural mimetics of metformin and rapamycin.

Aliper A, Jellen L, Cortese F, Artemov A, Karpinsky-Semper D, Moskalev A, Swick AG, Zhavoronkov A.

Aging (Albany NY). 2017 Nov 15;9(11):2245-2268. doi: 10.18632/aging.101319.

17.

Potentialities of MicroRNA Diagnosis in Patients with Bladder Cancer.

Shegay PV, Zhavoronkov AA, Gaifullin NM, Vorob'ev NV, Alekseev BY, Popov SV, Garazha AV, Buzdin AA, Kaprin AD.

Bull Exp Biol Med. 2017 Nov;164(1):106-108. doi: 10.1007/s10517-017-3935-3. Epub 2017 Nov 9.

PMID:
29119388
18.

γH2AX, 53BP1 and Rad51 protein foci changes in mesenchymal stem cells during prolonged X-ray irradiation.

Tsvetkova A, Ozerov IV, Pustovalova M, Grekhova A, Eremin P, Vorobyeva N, Eremin I, Pulin A, Zorin V, Kopnin P, Leonov S, Zhavoronkov A, Klokov D, Osipov AN.

Oncotarget. 2017 Jul 12;8(38):64317-64329. doi: 10.18632/oncotarget.19203. eCollection 2017 Sep 8.

19.

Bioinformatics Meets Biomedicine: OncoFinder, a Quantitative Approach for Interrogating Molecular Pathways Using Gene Expression Data.

Buzdin AA, Prassolov V, Zhavoronkov AA, Borisov NM.

Methods Mol Biol. 2017;1613:53-83. doi: 10.1007/978-1-4939-7027-8_4.

PMID:
28849558
20.

Mathematical Justification of Expression-Based Pathway Activation Scoring (PAS).

Aliper AM, Korzinkin MB, Kuzmina NB, Zenin AA, Venkova LS, Smirnov PY, Zhavoronkov AA, Buzdin AA, Borisov NM.

Methods Mol Biol. 2017;1613:31-51. doi: 10.1007/978-1-4939-7027-8_3.

PMID:
28849557

Supplemental Content

Loading ...
Support Center